Adam Craig
Tracked across 1 events · 7 articles · First seen Sep 08, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
X4 Pharmaceuticals announced a positive outcome from its Type C meeting with the United States — Food and Drug Administration regarding the global 4WARD Phase 3 clinical trial for mavorixafor in chronic neutropenia. The FDA…
Impact: Adam Craig is the Executive Chairman of X4 Pharmaceuticals and is quoted in the announcement. His role is to communicate the company's strategy and expectations, but he is not directly impacted by the event.
Sep 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Adam Craig live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard